News Articles and Montana BioScience Alliance Newsletters

MONTANA BIOSCIENCE ENTERPRISES IN THE NEWS

For a fifth straight year, Montana State University recorded an all-time high for research expenditures — the funding put toward scientific discovery and other scholastic and creative pursuits. MSU is the largest research enterprise in the state, and its total expenditures exceed the research expenditures of all other institutions in the state combined.

Central Montana Medical Center
|
September 19, 2023

Central Montana Medical Center has broken ground on a $15.6 million cancer center that will bring comprehensive cancer care services to central Montana. That means residents living in central and northern Montana won’t have to travel as long for cancer treatment.

A vaccine to prevent overdosing on fentanyl and one for heroin are in the works at the University of Montana and partner institutions. Human trials are expected to start in early 2024 for both vaccines, according to UM.

Only three years after its creation, the University of Montana and University of Montana Foundation today announced a significant investment to benefit the L.S. Skaggs Institute for Health Innovation. Known as SIHI, the institute will use this investment to expand its influence as a statewide hub for health education, research and outreach — with a goal of improving access to emerging health innovations for all Montanans.

Montana State University
|
August 22, 2023

Fifty-three high school graduates from across Montana have been selected for their effort and potential as the eighth class of Montana State University’s Hilleman Scholars Program, which is named after Maurice Hilleman, one of the state’s most influential native sons and an MSU graduate.

ARTICLES OF INTEREST

When her husband was undergoing cancer treatment, Cindy Perez of Southwest Ranches, Fla., learned about a new blood test that could help find early cancers. The 50-year-old said she felt fine, but her husband urged her to take the test anyway.

National Institutes of Health
|
March 26, 2024

Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus.

BIO.News
|
January 30, 2024

As a new year begins in Congress, the Biotechnology Innovation Organization (BIO) is carrying over many of its legislative priorities from last year.

NIH National Institute on Aging
|
January 18, 2024

Administrative Supplements to Promote Diversity in Research and Development Small Businesses – SBIR/STTR

National Institutes of Health SEED
|
January 18, 2024

Contract Pre-solicitation for R&D that will contribute toward ARPA-H mission needs and SBIR program objectives.

NEWSLETTER

Newsletter
|
May 7, 2024

View the Spring 2024 Newsletter now!

Newsletter
|
February 20, 2024

View the Winter II 2024 Newsletter now!